ExodusPoint Capital Management, LP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$913,033

-$151,489 QoQ

Shares Held

248,783

-28.3% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#75

of 344 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. RXRX ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$913,033	248,783	-28.3%	Shares	Sole	2026-08-14
2026-03-31	$1,064,522	346,750	-11.5%	Shares	Sole	2026-05-14
2025-12-31	$1,602,466	391,801	+90.9%	Shares	Sole	2026-02-17
2025-09-30	$1,001,556	205,237	+351.9%	Shares	Sole	2025-11-14
2025-06-30	$229,789	45,413	-26.4%	Shares	Sole	2025-08-13
2024-03-31	$615,039	61,689	+98.1%	Shares	Sole	2024-05-14
2023-03-31	$207,683	31,137	-32.1%	Shares	Other	2023-05-11
2022-09-30	$487,652	45,832	-76.1%	Shares	Sole	2022-11-10
2022-06-30	$1,563,474	192,073	+469.7%	Shares	Sole	2022-08-22
2022-03-31	$241,385	33,713	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.